• Journal of Science Education
• /
• v.43 no.3
• /
• pp.400-416
• /
• 2019

The purpose of this study is to find ways to improve education about safe medication use by investigating the current status of medication use by middle and high school students, and by evaluating their knowledge, attitudes, practices and education needs toward safe medication use. For this purpose, a survey was administered to 200 middle and high school students in Seoul and Gyeonggi Province. Over the past year, 92.0% and 57.5% of respondents used over-the counter drugs and prescription drugs at least one time, respectively. Regarding the experience of education on safe medication use, 34.0% of respondents have been educated more than once since their admission to middle school. The overall mean score of knowledge·attitude·practice (KAP) toward safe medication use was 3.79, but the mean score of practice scope was relatively lower than the others. Moreover, there were no significant differences in KAP scores for safe medication use by school grade or educational experience. Based on these findings, we suggest further studies regarding 1) expansion and differentiation of education content on safe medication use, 2) transition of education method to outcome-based education approach, and 3) inclusion of education on safe medication use in the regular curriculum of middle and high schools.

• Korean Journal of Clinical Pharmacy
• /
• v.20 no.1
• /
• pp.66-71
• /
• 2010

주의력결핍 과잉행동장애는 미국에서 약 200만 명의 어린이에게 나타나는 심각한 만성 신경행동학적 장애이다. 주의력결핍 과잉행동장애 치료의 중심은 약물요법이다. 그러나 현재 환자의 약 30%는 주의력결핍 과잉행동장애를 적응증으로 갖도록 허가된 의약품들을 사용해도 적절한 치료효과를 얻지 못하고 있는 상황이다. Modafinil은 methylphenidate나 amphetamines와 같은 각성제와는 다른 약리학적 기전으로 중추신경계를 항진시킨다. 본 연구는 modafinil의 주의력결핍 과잉행동장애 치료효과에 대한 최신 지견을 얻고자, 1990년부터 2010년 3월까지 MEDLINE에 등재된 논문을 ADHD와 Modafinil이라는 MeSH terms로 검색하여 추출한 자료 중에서 대조군이 사용된 무작위 배정 및 이중맹검 임상연구 사례만을 선별하여 임상적 유용성을 평가하였다. 현재 modafinil은 주의력결핍 과잉행동 장애 치료제로 허가된 의약품은 아니지만 최근 여러 국가에서 시행된 연구들은 modafinil이 안전하고 효과적인 주의력결핍 과잉행동장애 치료제일 수 있다는 결과를 보여주고 있다.

• Journal of Industrial Convergence
• /
• v.21 no.9
• /
• pp.23-32
• /
• 2023

Interest in Serious Games for Healthcare (SGHs) that can improve health through games is increasing. Digital Therapeutics (DTx) is a treatment that must be approved for effectiveness and safety, so it should follow the traditional drug distribution method, but SGHs are wellness products that are more flexible in terms of adoption and diffusion than DTx. SGHs are effective because it can provide customized services through continuous monitoring and feedback. When SGHs are applied to cognitive impairment treatment or behavioral correction, malfunctions and side effects are minor. This study developed research model based on the Valence Framework, gathered data from 142 undergraduates, and demonstrated that only the perceived benefits have a statistically significant positive (+) effect on SGHs acceptance intentions. Based on these results, this study suggests that SGHs companies should promote benefits in accepting SGHs for general users and they need for a distribution and analytics platform strategy based on a data-driven approach.